Executive Management Board

The CEO and, under his direction, the other EMB members are responsible for the Group’s overall business and day-to-day management. The EMB is also responsible for the implementation of strategic decisions and stakeholder management. The CEO reports to the Board regularly and whenever extraordinary circumstances so require. Each member of the EMB is appointed and discharged by the Board of Directors.

The EMB comprises 12 members under the leadership of, and including, the CEO, Guillaume Daniellot.  

Straumann Executive Management Board – Memberships on other boards

Guillaume Daniellot

Companies/organizations Location Function

Rodenstock GmbH (listed company)

DE

Advisory board member

Straumann Group Foundation (non-for-profit organization) CH Foundation board member

Isabelle Wege

Companies/organizations Location Function

Elis SA (listed company)

FR

Board member (member of the audit committee)

Grant Bester

Companies/organizations Location Function

Gyrus Capital (private company)

CH

Operating advisory board member

Neo Medical (private company) CH Advisory board member

Florian Kirsch

Companies/organizations Location Function

3D Diagnostix, Inc. (Straumann Group company)

CH

Board member

Digital Design Solutions S.A.E. (Straumann Group company) EG Board member

Dental Monitoring SAS (Straumann Group company)

FR Strategic committee member
Smilecloud S.r.l. (Straumann Group company) RO Board member

Patrick Loh

Companies/organizations Location Function

Essence & DM Dental Industry Investment Partnership (private company)

CN

Advisory chair

AOMI – Academy of Oral and Maxillofacial Implantologists (non-for-profit organization) CN Founding member, board member and general secretary

Arnoud Middel

Companies/organizations Location Function

Swisscontact (listed company)

CH

Member of the foundation council

Sébastien Roche

Companies/organizations Location Function

Orifarm Group A/S (private company)

DK

Board member

Andreas Utz

Companies/organizations Location Function

Botiss medical AG  (Straumann Group company)

DE

Supervisory board member

Biomimetic Innovations Limited  (Straumann Group company)

IE

Board member

Guillaume Daniellot, Isabelle Wege, Alexei Costa, Thomas Friese, Holger Haderer, Florian Kirsch and Patrick Loh are also board members in certain Straumann Group subsidiaries.

Permitted mandates outside Straumann Group
(pursuant to art. 626 II CO)

Art. 4.4 of Straumann’s Articles of Association states that no member of the EMB may perform more than five mandates in comparable functions in other companies with economic purpose, of which no more than one may be in listed companies.

The following are exempt from these restrictions:

  • Mandates in enterprises that control the Group or are controlled by the same 
  • Mandates in enterprises that are performed at the instruction of the Group 
  • Mandates in associations, organizations, foundations, trusts and employee pension funds; no member of the Executive Management may perform more than three such mandates

Mandates in several legal entities under common control or under the same economic authority are deemed as one mandate

Management contracts

The Board of Directors and the EMB have not delegated any managerial powers to persons or companies outside the Group.

Changes of control and defense measures

The Articles of Association of Straumann Holding AG do not contain provisions for opting out or opting up. There are no change-of-control clauses included in agreements and schemes benefiting members of the Board of Directors or the Executive Management Board or other management staff.